A
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- 8-K163.5 KBAMYLIN PHARMACEUTICALS INCAug 13, 5:16 PM ET·0001193125-12-352731
- 419.9 KBAMYLIN PHARMACEUTICALS INCAug 10, 6:36 PM ET·0001264124-12-000189
- 432.9 KBAMYLIN PHARMACEUTICALS INCAug 10, 6:35 PM ET·0001264124-12-000186
- SC 13G/A19.4 KBAMYLIN PHARMACEUTICALS INCAug 10, 12:16 PM ET·0000902219-12-000562
- SC 13G/A7.6 KBAMYLIN PHARMACEUTICALS INCAug 10, 11:06 AM ET·0000315066-12-003846
- SC 13D/A143.1 KBAMYLIN PHARMACEUTICALS INCAug 8, 5:10 PM ET·0000928464-12-000195
- 10-Q9.5 MBAMYLIN PHARMACEUTICALS INCAug 3, 4:25 PM ET·0000881464-12-000017
- 45.4 KBAMYLIN PHARMACEUTICALS INCJul 3, 7:00 PM ET·0000881464-12-000009
- 8-K528.4 KBAMYLIN PHARMACEUTICALS INCJul 2, 7:27 PM ET·0001193125-12-292510
- 8-K49.2 KBAMYLIN PHARMACEUTICALS INCJun 29, 10:02 PM ET·0001193125-12-290439
Insiders
10- ADAMS ADRIANDirector
- ALTMAN STEVEN RDirector
- BARON ALAIN DSr VP Research
- BECK TERESADirector
- BEHRENS M KATHLEENDirector
- BLACK BEAR OFFSHORE MASTER FUND LP10% Owner
- BRADBURY DANIELDirector, President & Chief Executive Of
- BROWN MARTIN RSr VP Human Resources and Corp
- BRYSON VAUGHN DDirector
- CLARK PAUL NDirector
Tickers
No tickers on record
Addresses
business
9360 TOWNE CENTRE DR SUITE 110
SAN DIEGO, CA, 92121
mailing
9360 TOWNE CENTRE DR SUITE 110
SAN DIEGO, CA, 92121